VENTANA anti-p40 (SP225) Rabbit Monoclonal Primary Antibody - HSA Registration DE0509796
Access comprehensive regulatory information for VENTANA anti-p40 (SP225) Rabbit Monoclonal Primary Antibody in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0509796 and owned by Ventana Medical Systems, Inc.. The device was registered on September 17, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Anti-p40 (SP225) Rabbit Monoclonal Primary Antibody is intended for laboratory use in the qualitative immunohistochemical detection of the p40 protein by light microscopy in formalin-fixed, paraffin-embedded tissue stained on a BenchMark IHC/ISH instrument. This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls. This antibody is intended for in vitro diagnostic (IVD) use.